Antimicrobials and QT prolongation
Open Access
- 4 February 2017
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 72 (5), 1272-1274
- https://doi.org/10.1093/jac/dkw591
Abstract
Solithromycin, a ketolide/macrolide antibiotic, has recently been reported to be free of the expected QT-prolonging effect of macrolides. It appears that its keto substitution provides a structural basis for this observation, as the other two tested ketolides also have minimal QT effect. Among non-cardiovascular therapies, antimicrobials probably carry the greatest potential to cause cardiac arrhythmias. This is a result of their propensity to bind to the delayed rectifier potassium channel, IKr, inducing QT prolongation and risk of torsades de pointes ventricular tachycardia, their frequent interference with the metabolism of other QT prolongers and their susceptibility to metabolic inhibition by numerous commonly used drugs. Unfortunately, there is evidence that medical practitioners do not take account of the QT/arrhythmia risk of antimicrobials in their prescribing practices. Education on this topic is sorely needed. When a macrolide is indicated, a ketolide should be considered in patients with a QT risk.This publication has 27 references indexed in Scilit:
- Solithromycin, a novel macrolide, does not prolong cardiac repolarization: a randomized, three-way crossover study in healthy subjectsJournal of Antimicrobial Chemotherapy, 2016
- Which QT Correction Formulae to Use for QT Monitoring?Journal of the American Heart Association, 2016
- Comparison of Formulas for Calculation of the Corrected QT Interval in Infants and Young ChildrenThe Journal of Pediatrics, 2015
- Association of Azithromycin With Mortality and Cardiovascular Events Among Older Patients Hospitalized With PneumoniaJAMA, 2014
- Allosteric effects of erythromycin pretreatment on thioridazine block of hERG potassium channelsBritish Journal of Pharmacology, 2014
- Antibiotic‐induced Cardiac ArrhythmiasCardiovascular Therapeutics, 2014
- Azithromycin and the Risk of Cardiovascular DeathThe New England Journal of Medicine, 2012
- In-vitro experimental models for the risk assessment of antibiotic-induced QT prolongationEuropean Journal of Pharmacology, 2006
- Assessment of the effect of a single oral dose of telithromycin on sotalol‐induced qt interval prolongation in healthy womenBritish Journal of Clinical Pharmacology, 2005
- QT Prolongation Associated with Azithromycin/Amiodarone CombinationPacing and Clinical Electrophysiology, 2001